Data / Form D filings / Sigma Pharmaceuticals Ltd
Sigma Pharmaceuticals Ltd: Form D filing
Sigma Pharmaceuticals Ltd, a pharmaceuticals company in South Croydon, Victoria, filed a Form D with the SEC in 2009. The latest, on September 24, 2009, reports $18.2 million sold of a $18.2 million offering to 13 investors.
Find out what Sigma Pharmaceuticals Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 96 MERRINDALE DRIVE, South Croydon, Victoria, 3136
- Phone
- 61 3 9839 2800
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Australia
- Revenue range
- Over $100,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1472870
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 24, 2009 | New notice | $18,215,562 | $18,215,562 | $0 | 13 | Sep 23, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Ellis | Executive Officer | |
| Linda B Nicholls | Director | |
| David S Bayes | Director | |
| Craig Tomlinson | Executive Officer | |
| Geoffrey D W Curlewis | Director | |
| Michael Long | Executive Officer | |
| Elmo de Alwis | Director | |
| James Barrie | Executive Officer | |
| Ian Finlay | Executive Officer | |
| Sue Morgan Dethick | Executive Officer | |
| Mark Smith | Executive Officer | |
| William J Scott | Director | |
| Jackie Toh | Executive Officer | |
| John W Stocker AO | Director | |
| Steve Waller | Executive Officer | |
| Keith Jeffs | Executive Officer | |
| Brian Jamieson | Director | |
| Peter Tilley | Executive Officer |
Every Form D from the week of Sep 21, 2009 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sigma Pharmaceuticals Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.